Prof. Dr. med. Eckhart Kämpgen
Renowned Dermatologist | Expert in Immunotherapy & Skin Cancer Research
Prof. Dr. med. Eckhart Kämpgen is a highly esteemed dermatologist, immunologist, and skin cancer specialist with over three decades of experience in oncology, allergology, and immunotherapy. His pioneering work in cellular immunotherapy and skin cancer treatment has led to groundbreaking advancements in dermatological research and clinical practice.
Academic Excellence & Medical Training
Prof. Kämpgen’s medical journey began with his studies in human medicine at the Universities of Essen and Munich, where he earned his medical license in 1987. That same year, he passed the American medical state examination, demonstrating his global medical competence.
- 1987 – Earned his medical degree from the University of Munich
- 1987–1988 – Research assistant at the Immunogenetic Laboratory, Institute of Immunology, University of Munich
- 1989 – Doctorate summa cum laude on the immunogenetic basis of “Erythema exsudativum multiforme”, a rare post-infectious skin reaction
- 1988–1990 – Scholarship holder of the German Research Foundation, conducting advanced immunological research at the University Dermatology Clinic in Innsbruck
- Further dermatological training at the University Dermatology Clinic in Würzburg
Clinical & Research Leadership in Dermatology
Prof. Kämpgen has held leading positions in prestigious university hospitals, specializing in melanoma, allergology, and dermatological oncology. His contributions to dermatological research, particularly in immunotherapy and skin cancer treatment, have significantly influenced modern dermatology.
- 1996 – Appointed Senior Physician at the University Dermatology Clinic Würzburg, specializing in allergology and oncology (melanoma)
- Established a research group focused on the biology of epidermal Langerhans cells and dendritic cells, leading to the first successful cancer vaccinations for melanoma and childhood glioblastoma
- 2001–2004 – Member of the Board of Directors of the Working Group for Dermatological Research within the German Dermatological Society, serving as Chairman in 2002
- 2002 – Visiting Professor at Duke University, North Carolina, USA, and Immunological Director at Merix Biotech, specializing in cellular vaccine production
- 2003 – Appointed C3 Professor at Friedrich Alexander University Erlangen, focusing on strategies for cellular immunotherapy
- 2010 – As Coordinator of the Skin Cancer Center, played a crucial role in achieving its certification and leading over 20 clinical studies on innovative skin cancer treatments, including:
- Sorafenib
- Vemurafenib
- Dabrafenib
- Trametinib
- Nivolumab
- Ipilimumab
Extensive Clinical Experience & Patient-Centered Approach
With over 17 years of clinical leadership as Senior Physician in top-tier university hospitals, Prof. Kämpgen has been responsible for:
- Management of dermatology outpatient clinics
- Specialized consultations in allergology and melanoma/oncology
- Development of cutting-edge treatments for skin cancer and immune-based therapies
His treatment philosophy is deeply rooted in scientific innovation and personalized patient care, ensuring that each patient receives the most advanced and effective treatment options available.
DERMATOLOGIKUM BERLIN & Ongoing Contributions
In 2013, Prof. Kämpgen co-founded DERMATOLOGIKUM BERLIN alongside Prof. Trefzer, Prof. Reich, and Prof. Steinkraus, establishing one of the leading centers for dermatological research, advanced skin cancer treatments, and immunotherapy.
Through his unwavering dedication to dermatological oncology and immunotherapy, Prof. Dr. med. Eckhart Kämpgen continues to be a trailblazer in the field, shaping the future of skin cancer treatment and immune-based therapies.